For: | Barone M. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications? World J Gastroenterol 2024; 30(18): 2391-2396 [PMID: 38764773 DOI: 10.3748/wjg.v30.i18.2391] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i18/2391.htm |
Number | Citing Articles |
1 |
Shihao Zheng, Chengyuan Xue, Size Li, Wenying Qi, Xiaobin Zao, Xiaoke Li, Wei Wang, Qiyao Liu, Xu Cao, Peng Zhang, Yongan Ye. Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways. The American Journal of Chinese Medicine 2024; 52(06): 1693 doi: 10.1142/S0192415X24500666
|
2 |
Shihao Zheng, Tianyu Xue, Qiuyue Wang, Pingxin Zhang, Wenying Qi, Chengyuan Xue, Xiaoke Li, Hongbo Du, Peng Zhang, Xiaobin Zao, Yongan Ye. Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy. The American Journal of Chinese Medicine 2025; : 1 doi: 10.1142/S0192415X25500168
|
3 |
Yun Hua, Xinrong Zhao, Na. Tang, Huijuan Wan, Haidong Lian, Ting Yuan, Chao Si. Function of AMPK/mTOR Signaling in TGF-β1-Induced Pterygium Fibroblast Proliferation and Transdifferentiation. Current Eye Research 2025; : 1 doi: 10.1080/02713683.2025.2470410
|